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To report on a suspected case of idiopathic radiation recall dermatitis in an individual nine months after radiation and chemo-
therapy treatment of squamous cell carcinoma of the right tonsil. Radiation recall dermatitis is the development of a reaction in a
previously irradiated area of skin after the administration of an aggravating medication. A review of the literature revealed several
cases of radiation recall dermatitis that occur following radiation therapy and the institution of chemotherapy. Other medications
havealsobeenimplicatedinradiationrecalldermatitis;however,thispatienthasnotstartedanynewmedicationssincecompletion
of his combined therapy. The patient developed this skin reaction in a distribution pattern identical to the area that received the
highest radiation dose suggesting a possible link between radiation recall dermatitis and radiation dose. Radiation recall dermatitis
is a reaction that is typically seen shortly after the reinstitution of chemotherapy during radiation therapy. This case illustrates that
other medical etiologies are possible and suggests a relationship between radiation recall dermatitis and the total radiation dose an
area receives.
1.Introduction
Radiation recall dermatitis is the development of a derma-
tologic reaction in a previously radiated area of skin after
the administration of an aggravating medication. The ﬁrst
case of radiation recall dermatitis was reported in 1959 by
D’Angio et al. who noticed the reaction following treatment
with dactinomycin [1]. Here we present a case of idiopathic
radiation recall dermatitis that developed nine months after
concurrent radiation therapy and cisplatin chemotherapy.
2.CaseReport
Thepatientisa49-year-oldCaucasianmalethatinitiallypre-
sented with a three-to-four month history of unilateral ton-
sillar swelling. Computer tomography of the neck revealed
bilateral tonsillar enlargement, right greater than left, with a
right internal jugular chain lymph node measuring 1.5cm by
1.5cm.Thepatientunderwentabilateraltonsillectomywith-
out complications. Pathology of the left tonsil was benign,
but the right tonsil contained a 2.4cm, poorly diﬀerentiated,
squamous cell carcinoma. The remainder of his staging
work-up was negative, and he was staged with T2N1M0,
StageIIIinvasivesquamouscellcarcinomaoftherighttonsil.
Combined modality therapy with concurrent cisplatin
chemotherapy and daily radiation therapy was initiated. The
tumor bed and ipsilateral neck were treated with 200 centi-
Gray (cGy) fractions to 7,000cGy, while the contralateral
neck received 170cGy fractions to 5,600cGy. The cisplatin
therapy was administered at a dose of 100mg per meter
squared on days one, twenty-two and forty-three of his six2 Case Reports in Oncological Medicine
weeks of radiation. The patient was able to complete his
treatment as prescribed without the need for a treatment
break. He developed grade II erythema within the radiation
ﬁeld on bilateral necks, dysgeusia, xerostomia, and mucositis
symptoms but otherwise did well.
Following completion of his treatment, the patient was
able to return to work and displayed regular improvement
during his scheduled follow-up visits. The erythema that
developed during his treatment had completely resolved and
the patient regularly reported feeling well. Approximately
nine months after his last radiation or chemotherapy treat-
ment, the patient reported to the clinic for routine followup.
He noted a twenty-four hour history of a tender, hot,
conﬂuent rash on his right neck that began at his clavicle
and extended superiorly to the mandibular angle (Figures 1
and 2). He reported an oral temperature of 102F; his tem-
perature in the clinic was 101.2F. He also experienced
some myalgias and arthralgias but denied constitutional
symptoms of nausea, vomiting, weight loss, drenching night
sweats, and fatigue. He denied any respiratory symptoms,
cough, hemoptysis, or bone pain. The patient had received
no interval chemotherapy and had not started any new
medications since his last visit. Radiation recall dermatitis
was suspected in this patient given the distribution of the
rash and presenting symptoms. Due to the warmth of the
tissue and the fever, there was some concern for cellulitis
as well, which prompted treatment with doxycycline. The
patient was seen several months after this clinical encounter
for routine followup and reported that his rash resolved in
the ﬁve to six days following the initial presentation. He
continued to report experiencing xerostomia and dysgeusia;
he denied any recurrence of his rash.
3. Discussion
Radiation recall dermatitis is the development of a localized
skinreactionfollowingradiationtherapythatcanbeinduced
by a variety of medications. Some of the medications
implicated in this reaction include actinomycin [1], adri-
amycin [2], docetaxel [3], doxorubicin [4], gatiﬂoxacin [5,
6], gemcitabine [7], interferon alpha-2b [8], levoﬂoxacin
[9], paclitaxel [10], pemetrexed [11], simvastatin [12], and
tamoxifen [13] among others.
Of note in this case are both the distribution of the
radiation recall dermatitis and the timing of the reaction.
The patient received radiation along bilateral necks but only
developed a skin reaction in the area of the ipsilateral neck
that received the highest daily dosage and total dose during
treatment. This suggests that the development of radiation
recall dermatitis might be dependent on either the fraction
size, total radiation dose, or both.
Radiation recall dermatitis typically develops within days
ofinitiationoftheoﬀendingagent.Inabroadreviewofcases,
Camidge and Price determined the median interval between
radiation and chemotherapy was 39.5 days; however, the
longest interval between drug administration and skin reac-
tion was two months [14, 15]. In this patient, the reaction
was seen nine months following the ﬁnal dose of cisplatin
Figure 1: Lateral aspect of patient’s right neck demonstrating af-
fected area.
Figure 2: Anterolateral aspect of patient’s right neck.
suggesting that the window for developing the skin reaction
is signiﬁcantly longer than originally thought or another
etiology is responsible in this case. During this nine-month
period, the patient received no other cytotoxic, hormonal, or
antimicrobial pharmacotherapy, nor did he change any soap,
detergent, cologne, or skin care product.Case Reports in Oncological Medicine 3
4. Conclusion
Radiation recall dermatitis is an acute reaction that occurs
in previously irradiated skin following the administration
of an aggravating medication. The skin reaction typically
develops within a few days of administration of the involved
medication. We present a case of idiopathic radiation recall
dermatitis that developed nine months after the cessation of
chemotherapy with no new medications initiated during the
interim. This case suggests that radiation recall dermatitis
may have a more complex etiology than originally described.
This case also implicates that the fraction size or total
radiation dosage might also be important factors in the
development of the dermatologic reaction.
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